SGLT2is
This drug is selected. Its supporting articles are shown below.
Articles mentioning SGLT2is
8 articles · page 1 of 1…=111,357; e.g., empagliflozin, dapagliflozin, canagliflozin) or DPP4is (n=43,868; e.g., sitagliptin, linagliptin) without cross-exposu…
…ACE and 6.7, 6.4, and 9.3 for first AKI respectively. Receiving SGLT2is at discharge significantly reduced the risk of MACE (hazard rat…
… CI 47.2% to 54.7%) (8.2 million) met indications for either an SGLT2i or a GLP-1RA. Among those with indications for an SGLT2i specif…
… outcome (10%), and incident CKD stages 3–4 (23%) compared with glipizide. However, glyburide was associated with significantly higher ri…
…cial in these patients. Remarkably, the benefits of GLP-1RA and SGLT2i are independent of type 2 diabetes status or baseline renal fun…
…omes and 37% of its improvement in CV outcomes were mediated by finerenone’s effect on decreasing UACR.28 While achieving reduction in UAC…
…ns prioritised sodium-glucose co-transporter type 2 inhibitors (SGLT2is) (mean rank: RF: 2.6 (IQR: 2.3–3) vs EU: 2.3 (IQR: 2.2–2.5)), f…